脓毒性休克中血管升压药与糖皮质激素的升级策略
脓毒性休克定义为感染所致低血压和乳酸酸中毒需使用血管升压药,病死率30%-40%。本文以病例为基础讨论了一线升压药选择、血压目标、升压药给药途径、二线升压药使用及辅助药物等常见临床决策,并涉及恶化性休克的诊断方法、治疗和监测策略以及升压药撤药困难的处理方法。
要点
- 脓毒性休克定义为感染所致低血压和乳酸酸中毒需使用血管升压药,病死率30%-40%。
- 恶化性脓毒性休克的处理涉及一线升压药选择、血压目标、给药途径、二线升压药及辅助药物等多项治疗决策。
- 本文以病例为基础讨论了升压药撤药困难的处理方法。
- 本文还涉及恶化性休克患者的诊断方法、治疗和监测策略。
适用人群与场景
- 脓毒性休克患者,即感染所致低血压和乳酸酸中毒需使用血管升压药者。
诊断标准与关键阈值
- 脓毒性休克定义为感染所致低血压和乳酸酸中毒需使用血管升压药纠正。
证据类型、等级与局限
- 局限:原文未报告局限性
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「研究设计与关键结果」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Septic shock is defined by the need for vasopressor agents to correct hypotension and lactic acidosis resulting from infection, with 30%-40% case fatality rates. The care of patients with worsening septic shock involves multiple treatment decisions involving vasopressor choices and adjunctive treatments. In this edition of "How I Do It", we provide a case-based discussion of common clinical decisions regarding choice of first-line vasopressor, BP targets, route of vasopressor delivery, use of secondary vasopressors, and adjunctive medications. We also consider diagnostic approaches, treatment, and monitoring strategies for the patient with worsening shock, as well as approaches to difficult weaning of vasopressors.
参考来源
- Teja B, Bosch NA, Walkey AJ, et al. How We Escalate Vasopressor and Corticosteroid Therapy in Patients With Septic Shock. Chest. 2022. PMID: 36162481. doi:10.1016/j.chest.2022.09.019
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。